Navigation Links
GenTel claims $900,000 in federal grants this year for biochip research

hnological feasibility and credibility of applicant proposals. Phase I grants focus on early stage product development, whereas phase II awards are oriented toward product marketing and commercialization.

The competition is pretty tough, and as federal budgets get tighter and tighter its going to become even more competitive, Vodenlich said. He added that receiving the grants was a big bo......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 07/14/04


Page: 1 2

Related biology technology :

1. GenTel acquires GlaxoSmithKline chip platform
2. New angel capital centered on GenTel agreement with big pharma
3. GenTel licenses next generation cancer research
4. GenTel to distribute cancer research tool
5. GenTel gets federal grant to develop allergy test
6. Madisons GenTel partners with Taiwan firm
7. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
8. GenTel BioSurfaces launches new assay platform
9. GenTel will sell Dutch firms biomolecule labeling technology
10. Bone Care, GenTel, MyWeather
11. GenTel receives $250,000 state loan

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: GenTel claims federal grants this year for biochip research

(Date:11/25/2009)...dor to Speak at Economic Club of Canada , ...25, 2009 -- Ambassador to Speak at Economic Club o...sador for International Investment, and Chairman a...iography of David Appia go to www.investinfrance....o meet with press to discuss recent pro-business i...
(Date:11/25/2009)...-Asia/--SinovacBiotechLtd.(SVA),aleadingdeveloper...,ajointventure(JV)agreementtoestablishSinovac(Dali...willresearch,develop,produce,andcommercializehuman...experienceindevelopingandcommercializingworld-clas...manufacturingfacilitiesand,establishedoperatinginf...
(Date:11/24/2009)...German . , Whether it,s CD packaging, contai...quency Identification) are increasingly finding th...to label objects or goods and identify them automa...r can read and process the data contained in the l...roduction conditions of up to 100 degrees Celsius....
(Date:11/24/2009)... York investment bank KTA Capital,s client Neuren ... mil convertible note private placement with a U.S...s arranged by KTA Capital as Neuren,s exclusive pl... New York (PRWEB) November 23, 2009 -- The inde...("KTA Capital") has announced that its c...
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...GO, Aug. 18 LifeVantage Corporation,(OTC Bulletin... product,clinically proven to slow the progressive... President & CEO, David Brown, is featured in an,e...Show., The interview gives viewers an overview of...s latest press release., To view the clip in i...
..., Aug. 18 /Xinhua-PRNewswire-FirstCall/ -- Yongye ...ard: YGYB) ("Yongye" or the "Company"),a leading d...r plants and,animals in the People,s Republic of C...e quarter ended June 30, 2008., Second Quarter 2...ncrease of 136.6% from the second quarter of 2...
...LPHIA, Aug. 17 /Xinhua-PRNewswire/ -- WuXi AppTec,...YSE: WX ) in the U.S., has announced,the appointm...erations and,Joseph Hughes, Ph.D. as Vice Presiden...y., (Logo: http://www.newscom.com/cgi-bin/prnh/2...e company for nine years in roles of,increasing re...
Other Biology Technology:[video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.net's 3-Minute Press Show 2Yongye Biotechnology International Announces Second Quarter Results 2Yongye Biotechnology International Announces Second Quarter Results 3Yongye Biotechnology International Announces Second Quarter Results 4Yongye Biotechnology International Announces Second Quarter Results 5Yongye Biotechnology International Announces Second Quarter Results 6Yongye Biotechnology International Announces Second Quarter Results 7Yongye Biotechnology International Announces Second Quarter Results 8Yongye Biotechnology International Announces Second Quarter Results 9Yongye Biotechnology International Announces Second Quarter Results 10Yongye Biotechnology International Announces Second Quarter Results 11WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility 2
(Date:11/24/2009)... constitutes fish food is a matter of debate. A hi...sh get almost 50 percent of their carbon from tree...en the terrestrial and aquatic ecosystems. , But...ows this is not likely to be true. Algae provide a... according to research published this week in the ...
(Date:11/23/2009)...NNATINew research presents strong evidence that th...oth outdoor traffic-related pollution and indoor e... one or the other exposure alone. , Environmen...ati (UC) College of Medicine have shown that child... particles and indoor endotoxin during early life ...
(Date:11/23/2009)...ONTO, November 23, 2009 - The time of day matters ... a new paper produced by a research team led by Pr...arborough,s vice-principal for research and collea... at the St. George campus. , Capitalizing on t...lar tree, the research team examined how poplar tr...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M 28TM 29 Littmann 28R 29 at American Heart Association Conference 6266 1Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M 28TM 29 Littmann 28R 29 at American Heart Association Conference 6266 2Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M 28TM 29 Littmann 28R 29 at American Heart Association Conference 6266 3Telik Announces Third Quarter 2009 Financial Results 6261 1Telik Announces Third Quarter 2009 Financial Results 6261 2Telik Announces Third Quarter 2009 Financial Results 6261 3Hip Fracture Odds Rise With Womens Age 61338 1
...may be one step closer to finding new drugs to fig... leading bioservices organisation announced that i...rsity of Strathclyde. , CABI houses one of the wor..., numbered at over 28,000 strains, including Flemi...will be supplying the University of Strathclyde’s ...
...lated neurological diseases are associated with de...esting that the cell’s normal disposal mechanisms ...he University of Pennsylvania School of Medicine h... two major pathways for breaking down proteins and...degenerative diseases in a simple animal model. Th...
...s have discovered the most effective method yet to...ture’s most abundant sugar, to HFM, a chemical tha...ade from petroleum. It has been an elusive goal f...eplace crude oil as the root source for plastic, f...chemicals with inexpensive, nonpolluting renewable...
Other Biology News:Could fungal collection hold the key to new life-saving drugs? 2Penn researchers link cell's protein recycling systems 2Penn researchers link cell's protein recycling systems 3Plastic that grows on trees 2Plastic that grows on trees 3
Anti-Human DPPII / QPP / DPP7 Affinity Purified Polyclonal Antibody, Biotin Conjugated from R&D Systems
Rat Anti-Mouse Granzyme D Monoclonal Antibody, Unconjugated, Clone 190617 from R&D Systems
Mouse Anti-Human ADAM10 Ectodomain Monoclonal Antibody, Unconjugated, Clone 163003 from R&D Systems
Anti-Human Apolipoprotein B100 Affinity Purified Polyclonal Antibody, Unconjugated from R&D Systems
Biology Products: